The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine

Por Walsby, Elisabeth J., Coles, Steven J., Knapper, Steven, Burnett, Alan K.
Publicado em 2011